The PIONEER TEENS trial compared oral semaglutide at maximum tolerated doses with placebo in adolescents aged 10 to 17 years with T2D.

Phase 3 trial data show a synthetic semaglutide injection provides glycemic control comparable to Ozempic in patients with ...

The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers ...

A study published in Diabetes Care has found that incretin-based therapies, including liraglutide and sitagliptin, may offer ...

After the initiation of an AID system, glycemic control improved and the effect persisted throughout the study period. (HealthDay News) — Initiation of an automated insulin delivery (AID) system ...

All 4 T1D participants receiving SAB-142 showed C-peptide preservation with 3 of the 4 participants showing a super responder ...

Patients with type 2 diabetes (T2D) at an elevated risk for kidney failure may stand to gain the most renal benefit with intensive glycemic control, but they also face the highest overall risk for ...

Recent updates to the American Diabetes Association/European Association for the Study of Diabetes (ADA/EASD) guidelines have focused on the need for more intensive therapy in patients with type 2 ...

A recent study published in the Frontiers in Endocrinology found dietary fiber supplementation in high-risk pregnancies to be effective in improving 1-hour postprandial glucose control, ...

Relaxed glycemic control targets were associated with an increased risk for skin, bone, and soft tissue infections among older adults with type 2 diabetes. Older adults with type 2 diabetes and ...

The risk for poor glycemic control in patients with type 2 diabetes can be predicted with confidence by using machine learning methods, a new study finds. The most important factors predicting ...

Whole grains are an important inclusion in a nutritious diet. Whole grains, including whole grain breads, are less likely to ...